Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 695-700

  Maeda, Takafumi ^a   Suzuki, Koichi ^a   Togashi, Kazutomo ^a   Nokubi, Mitsuhiro ^a   Saito, Masaaki ^a   Tsujinaka, Shingo ^a   Kamiyama, Hidenori ^a   Konishi, Fumio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

BRAF mutation; CpG island methylator phenotype; Serrated neoplastic pathway; Sessile serrated adenoma

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PROTEIN MLH1;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; COLON ADENOMA; COLON CANCER; CPG ISLAND; EPIGENETICS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; SESSILE SERRATED ADENOMA;

EID: 79958058741     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.249     Document Type: Article

References (32)

1. Longacre TA and Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14: 524-537, 1990.
2. Torlakovic E, Skovlund E, Snover DC, Torlakovic G and Nesland JM: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27: 65-81, 2003.
3. Torlakovic EE, Gomez JD, Driman DK, et al: Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32: 21-29, 2008.
4. Torlakovic E and Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 110: 748-755, 1996.
5. Lee SK, Chang HJ, Kim TI, et al: Clinicopathologic findings of colorectal traditional and sessile serrated adenomas in Korea: a multicenter study. Digestion 77: 178-183, 2008.
6. Leggett B and Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100, 2010.
7. Higuchi T and Jass JR: My approach to serrated polyps of the colorectum. J Clin Pathol 57: 682-686, 2004.
8. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH and Issa JP: A simple method for estimating global DNA methylation using bisulfte PCR of repetitive DNA elements. Nucleic Acids Res 32: e38, 2004.
9. Sandmeier D, Benhattar J, Martin P and Bouzourene H: Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology 55: 206-213, 2009.
10. Carr NJ, Mahajan H, Tan KL, Hawkins NJ and Ward RL: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62: 516-518, 2009.
11. Kambara T, Simms LA, Whitehall VL, et al: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144, 2004.
12. Lash RH, Genta RM and Schuler CM: Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 63: 681-686, 2010.
13. O'Brien MJ, Yang S, Mack C, et al: Comparison of microsat-ellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30: 1491-1501, 2006.
14. Spring KJ, Zhao ZZ, Karamatic R, et al: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131: 1400-1407, 2006.
15. Farina-Sarasqueta A, van Lijnschoten G, Moerland E, et al: The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann Oncol 21: 2396-2402, 2010.
16. Watanabe T, Kobunai T, Toda E, et al: Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res 66: 9804-9808, 2006.
17. Cho YK, Kim HC, Kim SH, et al: Location-related differences in sporadic microsatellite unstable colorectal cancer. Dig Liver Dis 42: 611-615, 2010.
18. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
19. Chan TL, Zhao W, Leung SY and Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63: 4878-4881, 2003.
20. Takemoto N, Konishi F, Yamashita K, et al: The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration. Jpn J Clin Oncol 34: 90-98, 2004.
21. Xiong Z and Laird PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534, 1997.
22. Toyota M, Ho C, Ahuja N, et al: Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312, 1999.
23. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
24. Kusano M, Toyota M, Suzuki H, et al: Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 106: 1467-1479, 2006.
25. Kim YH, Kakar S, Cun L, Deng G and Kim YS: Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer 123: 2587-2593, 2008.
26. Vaughn CP, Wilson AR and Samowitz WS: Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol 23: 151-156, 2010.
27. Miyakura Y, Sugano K, Konishi F, et al: Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 121: 1300-1309, 2001.
28. Deng G, Chen A, Hong J, Chae HS and Kim YS: Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033, 1999.
29. Ogino S, Nosho K, Kirkner GJ, et al: CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58: 90-96, 2009.
30. Zlobec I, Kovac M, Erzberger P, et al: Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Int J Cancer 127: 2569-2575, 2010.
31. Lubomierski N, Plotz G, Wormek M, et al: BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors. Cancer 104: 952-961, 2005.
32. Jass JR, Baker K, Zlobec I, et al: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49: 121-131, 2006.